Lv5
1135 积分 2021-05-28 加入
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
3天前
已完结
ALK in cancer: from function to therapeutic targeting
14天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
14天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
14天前
已完结
Management of non-small-cell lung cancer: recent developments
17天前
已完结
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US
19天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
19天前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
19天前
已完结
Non-small-cell lung cancer
19天前
已完结
Mass-spectrometry-based proteomics: from single cells to clinical applications
25天前
已完结
皖公网安备34019202002308
